List of works - Jean-Michel Coindre

Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

scientific article published on 27 June 2010

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

scientific article published on 8 May 2011

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

scientific article

Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation

scientific article

Trends in survival for patients with metastatic soft-tissue sarcoma

scientific article published on 13 October 2010

MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema

scientific article

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis

scientific article

Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors

scientific article published on 13 December 2011

Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions.

scientific article published on 19 April 2012

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

scientific article published on 7 September 2015

Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas

scientific article published on 14 January 2013

Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.

scientific article published on 7 October 2014

Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma

scientific article published on 4 August 2010

Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib

scientific article published on 8 November 2011

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

scientific article

The value of research collaborations and consortia in rare cancers

scientific article published on February 2016

ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma

scientific article

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

scientific article published on 11 December 2015

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

scientific article

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

scientific article published on 25 April 2016

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

scientific article

Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics

scientific article

Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma

scientific article published on 21 April 2016

Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

scientific article

Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival

scientific article

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

scientific article published on 20 July 2017

Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy

scientific article published on 6 November 2014

Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis

scientific article

Improving treatment results with reference centres for rare cancers: where do we stand?

scientific article published on 3 April 2017

Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)

scientific article published on 08 September 2012

Dotlike or Golgi-like KIT and PDGFRA Staining in GISTs

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

scientific article published on 12 October 2017

Recommendations for the management of GIST patients

scientific article

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group

scientific article published on 5 April 2018

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

scientific article

Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers

scientific article

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol

scientific article published on 18 June 2019

List of works by Jean-Michel Coindre

Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation

Trends in survival for patients with metastatic soft-tissue sarcoma

MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis

Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors

Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions.

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas

Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.

Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma

Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

The value of research collaborations and consortia in rare cancers

ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics

Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma

Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy

Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis

Improving treatment results with reference centres for rare cancers: where do we stand?

Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)

Dotlike or Golgi-like KIT and PDGFRA Staining in GISTs

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

Recommendations for the management of GIST patients

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol

Reply to Y. Nishida et al

Erratum